| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/25/2013 | WO2013108105A2 Novel solvates of darunavir |
| 07/25/2013 | WO2013108026A1 Thiadiazolone derivatives useful in the treatment of diabetes |
| 07/25/2013 | WO2013107883A1 Tetrahydrofolates in combination with egfr-inhibitors |
| 07/25/2013 | WO2013107882A1 Anti-tumor activity of reduced folates like methylene-tetrahydrofolate |
| 07/25/2013 | WO2013107862A1 NOVEL 2-AMINO-4,5,6,8-TETRAHYDROPYRAZOLO[3,4-b]THIAZOLO [4,5-d]AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS |
| 07/25/2013 | WO2013107856A1 Imidazole derivatives as pde10a enzyme inhibitors |
| 07/25/2013 | WO2013107839A2 Phospholipid compounds for use in skin cancer treatment |
| 07/25/2013 | WO2013107820A1 Novel fap inhibitors |
| 07/25/2013 | WO2013107810A1 Transmucosal administration system for a pharmaceutical drug |
| 07/25/2013 | WO2013107809A1 Use of azole antifungals for the treatment of actinic keratosis |
| 07/25/2013 | WO2013107761A1 Substituted triazoles and their use for treatment and/or prevention neurological and psychiatric disorders |
| 07/25/2013 | WO2013107743A1 Spiroindoline derivatives as gonadotropin- releasing hormone receptor antagonists |
| 07/25/2013 | WO2013107609A1 Systemic administration forms with controlled release and improved stability |
| 07/25/2013 | WO2013107515A1 Eye drop composition |
| 07/25/2013 | WO2013107503A1 Method for producing cinacalcet compositions for direct tableting |
| 07/25/2013 | WO2013107441A1 Process for producing a solid pharmaceutical composition comprising the active ingredient rasagiline |
| 07/25/2013 | WO2013107429A1 1-oxo/acylation-14-acylated oridonin derivative, preparation method therefor and application thereof |
| 07/25/2013 | WO2013107428A1 7-substituted hanfangichin b derivative, and preparation method and use thereof |
| 07/25/2013 | WO2013107427A1 Therapeutic compositions for intranasal administration of zolpidem |
| 07/25/2013 | WO2013107413A1 Use of phosphorylation pathway-related factor in regulating function of regulatory t cell |
| 07/25/2013 | WO2013107405A1 Therapeutically active compounds and their methods of use |
| 07/25/2013 | WO2013107336A1 Therapeutic uses |
| 07/25/2013 | WO2013107333A1 Piperazinyl pyrimidine derivatives, preparation method and use thereof |
| 07/25/2013 | WO2013107326A1 NEW-TYPE IMIDAZO [1, 2-a] PYRIDINE COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND USE THEREOF |
| 07/25/2013 | WO2013107291A1 Therapeutically active compounds and their methods of use |
| 07/25/2013 | WO2013107285A1 Amino heteroaryl compound, preparation method therefor and use thereof |
| 07/25/2013 | WO2013107283A1 Benzoheterocyclic compounds and use thereof |
| 07/25/2013 | WO2013107278A1 New-type anti-cancer compounds synthesized from reaction of ketone and indole derivatives |
| 07/25/2013 | WO2013107236A1 Crystal form of (6s)-5-methyltetrahydrofolate salt and method for preparing same |
| 07/25/2013 | WO2013107225A1 N-((4-chloro-3-trifluoromethyl)phenyl)-n'-(2-fluoro-4-((2-hydroxymethylaminoformyl)-4-pyridyloxo)phenyl)urea and use thereof as anti-cancer drug |
| 07/25/2013 | WO2013107206A1 Chinese herbal medicine composition for treating diabetic foot |
| 07/25/2013 | WO2013107189A1 Gambogenic acid derivatives, preparation method and application thereof |
| 07/25/2013 | WO2013107164A1 Novel indoleamine-2, 3-dioxygenase inhibitor, preparation method therefor and uses thereof |
| 07/25/2013 | WO2013106937A1 3' equatorial-fluorine-substituted neuraminidase inhibitor compounds, compositions and methods for the use thereof as anti-virals |
| 07/25/2013 | WO2013106934A1 Novel regulators of innate immunity and uses thereof |
| 07/25/2013 | WO2013106913A1 Biomarkers for breast cancer prognosis and treatment |
| 07/25/2013 | WO2013081563A3 Stable voglibose tablet formulations |
| 07/25/2013 | WO2013080217A3 Crystalline forms of carbazitaxel and process for preparation thereof |
| 07/25/2013 | WO2013079701A3 Expression of mirnas in placental tissue |
| 07/25/2013 | WO2013079204A3 4-phenylbutyric acid for cosmetic use |
| 07/25/2013 | WO2013078446A3 Derivatives of phenoxyisobutyric acid |
| 07/25/2013 | WO2013078199A3 Methods for enhanced in vivo delivery of synthetic, modified rnas |
| 07/25/2013 | WO2013073483A9 Method for producing myo-inositol and myo-inositol derivative |
| 07/25/2013 | WO2013070988A3 Method of treating osteosarcoma |
| 07/25/2013 | WO2013063271A4 Artemisinin and berberine compositions and methods of making |
| 07/25/2013 | WO2013057527A3 Compounds for treatment of ischemic injury |
| 07/25/2013 | WO2013055687A3 R(+)-n-formyl-propargyl-aminoindan |
| 07/25/2013 | WO2013055258A9 Use of glutaryl histamine to treat respiratory tract infections |
| 07/25/2013 | WO2013050987A9 Carbamate/ urea derivatives containing piperidin and piperazin rings as h3 receptor inhibitors |
| 07/25/2013 | WO2013045959A3 Camphene reduces plasma cholesterol and triglycerides |
| 07/25/2013 | WO2013042140A4 Non antibiotic, non peptide compounds for antibiotic efficacy & safety enhancement |
| 07/25/2013 | WO2013042124A8 Use of strigolactones and strigolactone analogs for treating proliferative conditions |
| 07/25/2013 | WO2013040492A3 Methods for treating hcv |
| 07/25/2013 | WO2013040227A3 Therapeutic compounds |
| 07/25/2013 | WO2013016531A3 Compounds and methods for use in treating neoplasia and cancer |
| 07/25/2013 | WO2013003114A8 Esters for treatment of ocular inflammatory conditions |
| 07/25/2013 | WO2012163928A3 Topical wash composition for use in acne patients |
| 07/25/2013 | WO2012162777A9 Oral pharmaceutical composition comprising a proton pump inhibitor and a prokinetic agent that can be used in excess stomach acid disorders |
| 07/25/2013 | WO2012111021A8 Substituted 1, 2, 3, 4-tetrahydroquinolin-7-yl carbamates as acetylcholinesterase inhibitors for treatment of alzheimer's disease |
| 07/25/2013 | WO2012022677A3 Combination therapy for the treatment of cancer |
| 07/25/2013 | US20130191934 Treatment of symptoms associated with menopause |
| 07/25/2013 | US20130191933 Methods of treating pain and morphine tolerance via modulation of hedgehog signalling pathway |
| 07/25/2013 | US20130190839 Drug delivery using a sacrificial host |
| 07/25/2013 | US20130190814 Internal Clamp for Surgical Procedures |
| 07/25/2013 | US20130190724 Prevention of indwelling device related infection: composition and methods |
| 07/25/2013 | US20130190503 Therapeutic agent or prophylactic agent for fibromyalgia |
| 07/25/2013 | US20130190496 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors |
| 07/25/2013 | US20130190495 Compositions and methods of treatment of cancer |
| 07/25/2013 | US20130190450 Cyclodextrin-based polymers for therapeutics delivery |
| 07/25/2013 | US20130190407 Calcium receptor-active molecules |
| 07/25/2013 | US20130190405 Methods and use of compounds that bind to her2/neu receptor complex |
| 07/25/2013 | US20130190403 Administration of intravenous ibuprofen to trauma patients |
| 07/25/2013 | US20130190402 Methods Of Treating Autism With mGluR5 Antagonists |
| 07/25/2013 | US20130190401 Veterinary dermatologic composition |
| 07/25/2013 | US20130190400 Method for producing gamma-aminobutyric acid and food produced thereby |
| 07/25/2013 | US20130190399 Synthesis and use of omega-3 and omega 6 very long chain polyunsaturated fatty acids (VLC-PUFA) |
| 07/25/2013 | US20130190396 Novel sulfonamide compounds for inhibition of metastatic tumor growth |
| 07/25/2013 | US20130190395 Autoimmune disorder treatment using rxr agonists |
| 07/25/2013 | US20130190394 Applications Of Arctigenin In Formulating Drugs For Preventing Or Treating Diseases Related To Red Blood Cell Reduction |
| 07/25/2013 | US20130190392 Method of preparing soy isoflavone nanoparticles by precipitation with compressed antisolvent (pca) using a supercritical fluid |
| 07/25/2013 | US20130190391 Traversal of nucleic acid molecules through a fluid space and expression in repair cells |
| 07/25/2013 | US20130190388 Methods and Compositions Related to DLK-1 and the P38 MAPK Pathway in Nerve Regeneration |
| 07/25/2013 | US20130190387 Treatment or prevention of oto-pathologies by inhibition of pro-apoptotic genes |
| 07/25/2013 | US20130190381 Inhibitors of long and very long chain fatty acid metabolism as broad spectrum anti-virals |
| 07/25/2013 | US20130190376 Methods of use of small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 07/25/2013 | US20130190374 Grm3 mutations and use thereof for the diagnosis and treatment of melanoma |
| 07/25/2013 | US20130190373 Angiotensin ii receptor antagonist for the prevention or treatment of systemic diseases in cats |
| 07/25/2013 | US20130190372 Bendamustine cyclopolysaccharide compositions |
| 07/25/2013 | US20130190371 Fungicide Active Substance Combinations |
| 07/25/2013 | US20130190370 Novel Tetrahydronaphalene Antagonists to the Thromboxane A2 (TP) Receptor |
| 07/25/2013 | US20130190365 Use of Deferiprone and Methods to Treat and/or Prevent Friedreich Ataxia Resulting from Intracellular Mishandling of Iron |
| 07/25/2013 | US20130190358 Novel orally administered dabigatran formulation |
| 07/25/2013 | US20130190354 Pharmaceutical compositions containing a dgat1 inhibitor |
| 07/25/2013 | US20130190351 Bicyclic amides for enhancing glutamatergic synaptic responses |
| 07/25/2013 | US20130190350 Mediators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto |
| 07/25/2013 | US20130190346 Method of reducing cns and gastrointestinal side affects associated with long-term, dextromethorphan/low-dose quinidine combination therapy |
| 07/25/2013 | US20130190343 Compositions and methods for minimizing or reversing agonist-induced desensitization |
| 07/25/2013 | US20130190342 COMPOSITIONS OF BUPRENORPHINE AND µ ANTAGONISTS |
| 07/25/2013 | US20130190341 High bioavailability opioid formulations |
| 07/25/2013 | US20130190336 Stable pharmaceutical compositions comprising a pyrimidine-sulfamide |